Bank Of Montreal Immunome Inc. Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$6.17 - $9.16 $47,761 - $70,907	-7,741 Reduced 7.72%	92,593 $773,000
Q2 2023 Aug 02, 2023	BUY	$4.7 - $7.91 $36,382 - $61,231	7,741 Added 8.36%	100,334 $793,000
Q1 2023 Jun 13, 2024	BUY	$3.26 - $5.69 $301,853 - $526,854	92,593 New	92,593 $462,000
Q3 2021 Nov 12, 2021	BUY	$12.5 - $27.76 $1.16 Million - $2.57 Million	92,593 New	92,593 $2.35 Million

122

47.1M

322K

1.91M

Ticker IMNM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,127,400
Market Cap $134M
Description
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.